Integra LifeSciences Cor...

NASDAQ: IART · Real-Time Price · USD
14.20
0.58 (4.26%)
At close: Aug 15, 2025, 3:59 PM
14.20
0.04%
After-hours: Aug 15, 2025, 05:41 PM EDT

Integra LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
8.74M -3.66M -6.94M -6.54M 23.65M 40.23M 67.74M 100.85M 131.27M 171.88M 180.55M 172.99M 166.3M 156.58M 169.07M 216.44M 205.54M 170.11M
Depreciation & Amortization
73.55M 110.33M 140.89M 133.82M 128.42M 122.47M 123.05M 122.02M 120.93M 119.72M 118.3M 119.55M 120.2M 120.35M 119.84M 115.27M 116.17M 116.09M
Stock-Based Compensation
11.53M 18.78M 24.38M 23.02M 24.09M 22.12M 20.14M 20.08M 23.59M 25.05M 27.73M 28.43M 27.2M 36.17M 36.21M 35.03M 32.7M 22.17M
Other Working Capital
8.13M -1.02M 11.89M 11.54M 2.15M 14.58M 36.45M 18.21M 34.63M 31.97M 6.27M -23.62M -28.56M -29.79M -27.35M 4.12M 4.64M 3.8M
Other Non-Cash Items
-24.42M 55.97M 67.4M 69.22M 93.83M 16.66M 236K -14.19M -29.02M -34.17M -18.1M -170.18M 5.26M 10.15M -28.1M 200.49M -7.77M -2.93M
Deferred Income Tax
-17.86M -19.71M -20.73M -28.59M -18.31M -16.69M -11.88M -3.06M -10.4M -6.18M -4.58M 12.18M 9.69M 2.02M -2.75M -82.42M -68.64M -70.44M
Change in Working Capital
10.43M 11.36M -11.99M 10.09M -46.38M -62.31M -59.33M -59.16M -28.29M -30.02M -39.42M -74.92M -65.79M -37.58M 18.16M 52.9M 32.27M 17.09M
Operating Cash Flow
59.63M 102.37M 129.38M 137.39M 141.68M 129.56M 139.96M 166.54M 208.08M 246.28M 264.47M 88.04M 262.88M 287.69M 312.43M 537.71M 310.27M 252.1M
Capital Expenditures
-69.2M -98.91M -114.37M -99.35M -82.78M -68.63M -66.86M -56.79M -52.86M -46.72M -47.09M -60.11M -58.24M -55.47M -48.08M -49.02M -48.46M -49.05M
Cash Acquisitions
4.18M -277.81M -277.81M -281.99M -281.99M n/a n/a -51.51M -27.55M -27.55M -27.55M -166.51M -191.74M -193.02M -303.91M -113.44M -112.17M -110.89M
Purchase of Investments
-4.13M -14.63M -53.13M -81.69M -81.69M -71.19M -32.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
54.5M 54.5M 54.5M 19.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-103.44M -56.37M -58.95M -81.69M -76.31M -65.81M -27.31M 16.53M 35.1M 40.01M 35.27M 340.08M 190.71M 185.81M 382.28M 58.84M 184.25M 187.52M
Investing Cash Flow
-108.13M -372.76M -390.81M -443.79M -441.09M -134.44M -94.18M -91.77M -69.27M -58.22M -58.58M 94.24M -54.52M -57.94M -161.44M -295.36M -168.12M -164.15M
Debt Repayment
14.87M -16.88M 299.37M 297.11M 391.75M 411.8M 54.2M -40.3M -121.7M -109.5M -107.8M -5.7M n/a -98.9M -100M -80.6M -108.7M -40.1M
Common Stock Repurchased
651K -49.35M -52.47M -50.31M -178.44M -128.54M -275.42M -275.38M -151.52M -165.41M -140.41M -140.66M -139.96M -126.16M -4.8M -4.67M -4.52M -4.36M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
49.31M 23.07M -9.04M -8.67M -8.06M 4.95M -8.81M -5.43M -7.02M -21.67M -20.39M -24.27M -20.59M -6.01M 1.77M 3.08M -3.62M -3.29M
Financial Cash Flow
22.55M -85.44M 237.86M 238.12M 208.38M 291.43M -229.93M -320.73M -278.72M -281.17M -251.95M -53.24M -144.35M -228.68M -98.23M -178.01M -112.32M -43.4M
Net Cash Flow
-4.59M -352.8M -30.03M -58.58M -403.15M -24.65M -489.45M -547.4M -137.96M -99.72M -56.79M 41.71M 49.74M -1.88M 43.28M 73.95M 36.43M 51.26M
Free Cash Flow
-9.57M 3.46M 15.01M 38.04M 58.89M 60.93M 73.09M 109.75M 155.22M 199.56M 217.38M 27.93M 204.63M 232.22M 264.35M 488.69M 261.81M 203.05M